Please use this identifier to cite or link to this item:
|Title:||Good publication practice for communicating company sponsored medical research: The GPP2 guidelines.|
Battisti, W. P.
Conaty, J. M
Ellison, J. M.
Yarker, Y. E.
|Citation:||Graf, C., Battisti, W. P., Bridges, D., Bruce-Winkler, V., Conaty, J. M., Ellison, J. M., … Yarker, Y. E. (2009). Good publication practice for communicating company sponsored medical research: The GPP2 guidelines. BMJ (Online), 339(7733), 1299–1303.|
|Abstract:||Authors and presenters are responsible for how medi- cal research is interpreted and communicated. Often their work is the product of collaborations with other individuals (such as clinical investigators, biostatisticians, and professional medical writers) from around the world. Some or all of the people who contribute to this col- laboration may be employees of research sponsors, con- tract research organisations, or medical communications agencies that may be funded by pharmaceutical, medi- cal device, or biotechnology companies. The authors, collaborators, and organisations share responsibility for developing articles and presentations in a responsible and ethical manner. The good publication practice (GPP2) guidelines pre- sented here make recommendations that will help indi- viduals and organisations maintain ethical practices and comply with current requirements when they contribute to the communication of medical research sponsored by companies. These guidelines apply to peer reviewed jour- nal articles and presentations at scientific congresses|
|Appears in Collections:||Ethics|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.